Immune modulation by phototherapy: Why immune suppression?

Expert Review of Dermatology

Volumn 3, Issue 1, 2008, Pages 7-9

  Ullrich, Stephen E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; DNA DAMAGE; DRUG RESPONSE; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION SENSITIVITY; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INJURY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SKIN BURNING SENSATION; SKIN CANCER; SKIN DISEASE;

EID: 40749162236     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.1.7     Document Type: Editorial

References (6)

1. Yang MF, Baron ED. Update on the immunology of ultraviolet and visible radiation therapy: phototherapy, photochemotherapy and photodynamic therapy. Expert Rev. Dermatol. (In Press) (2008).
2. Wolf P, Nghiem DX, Walterscheid JP et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am. J. Pathol. 169(3), 795-805 (2006).
3. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat. Res. 571(1-2), 185-205 (2005).
4. Kripke ML. Ultraviolet radiation and immunology: something new under the sun - presidential address. Cancer Res. 54(23), 6102-6105 (1994).
5. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J. Natl Cancer Inst. 53(5), 1333-1336 (1974).
6. Nishigori C, Yarosh DB, Ullrich SE et al. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Pro. Natl Acad. Sci. USA, 93 (19), 10354-10359 (1996).